STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #407 by analyst upside · 2026-08-13
ARDX
Ardelyx, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+227.5%
implied upside to consensus target
Current Price $3.97
Consensus Target $13.0
Bull Target $18.0
Bear Target $8.0
Analysts Covering 10
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
9
Hold
0
Sell
0
52-Week Low $3.89
52-Week High $8.4
YTD Return -35.4%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E 12.4x
EPS (TTM) $-0.23
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $451M
Profit Margin -12.4%
52-WEEK RANGE
52-Week Low $3.89
52-Week High $8.4
Current Price $3.97
Bear Target $8.0
Bull Target $18.0
● Now $3.97 ● Target $13.0
TRADING DATA
Avg Volume 4.1M
YTD Return -35.4%
Analyst Count 10
Consensus Buy
Upside to Target +227.5%
Last Updated 2026-08-13

ANALYST SUMMARY

Ardelyx, Inc. (ARDX) is currently trading at $3.97 with a Wall Street consensus price target of $13.0, implying potential upside of 227.5% over the next 12 months. 10 analysts currently cover ARDX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $18.0, while the most cautious has a target of $8.0.

ARDX operates in the Healthcare sector with a market capitalisation of $1B. The stock is down 35.4% year-to-date and is currently trading near the lower end of its 52-week range of $3.89 – $8.4.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ARDX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wedbush reit
Outperform → Outperform 2026-02-23 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-02-20 31% win rate (48 calls)
BTIG reit
Buy → Buy 2026-02-20 38% win rate (8 calls)
BTIG reit
Buy → Buy 2026-01-29 38% win rate (8 calls)
Wedbush - Reiterated
Outperform → Outperform 2026-01-21 Building track record
Citigroup - Reiterated
Buy → Buy 2026-01-09 Building track record
Piper Sandler ↑ Upgrade
Neutral → Overweight 2026-01-09 14% win rate (7 calls)
BTIG - Reiterated
Buy → Buy 2026-01-09 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
45
out of 100
Coverage depth
18/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →